In addition, the functional results reveal that genetic deletion or pharmacological inhibition of KDM4C suppressed tumor growth in vitro and in vivo, further supporting our hypothesis that KDM4C acts as an oncoprotein in lung cancer. Here, KDM4C is linked to lung cancer.